Trial
NCT06179407
Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Merck Sharp & Dohme LLC
Collaborators
—
Condition
Narcolepsy
Intervention
MK-6552
Why stopped
Terminated for business reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-14